Skip to content

Clearance of vasopressin and copeptin during hemodialysis

Clearance of vasopressin and copeptin during hemodialysis - Clearance during hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42330
Enrollment
15
Registered
2015-12-11
Start date
2015-12-14
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease

Interventions

None listed

Sponsors

Interne Geneeskunde, Nefrologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Thrice-weekly dialysis schedule, dialysis with a shunt.

Exclusion criteria

Exclusion criteria: Age under 18 Dialysis frequency other than thrice weekly Dialysis duration other than 4 hours Dialysis with a central venous catheter

Design outcomes

Primary

MeasureTime frame
Plasma vasopressin and copeptin levels before and during hemodialysis

Secondary

MeasureTime frame
Niet van toepassing / not applicable

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)